Avidicure BV

Avidicure B.V. operates as a biotechnology company. The Company specializes in developing dual agonistic, multifunctional, and avidity engineered antibody modality AVC-boosters designed to safely delivers targeted and potent immune-modulating monotherapy for cancer patients. Avidicure serves customers in the Netherlands.